Innovation and Biomedicine: Ethics, Evidence and Expectation in HIV
Innovation and Biomedicine: Ethics, Evidence and Expectation in HIV
复制标题
创新与生物医学：艾滋病毒的伦理、证据和期望
DOI：
--
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
M. Rosengarten
中科院分区：
文献类型：
--
作者：
M. Michael;M. Rosengarten
借鉴Whitehead，Deleuze和Stengers等过程思想家，创新和生物医学开发了一个分析生物医学创新的框架。由于其持续关注预防艾滋病毒感染的暴露前预防（PrEP）药丸，该卷通过离岸随机对照试验（RCT）探讨了药丸测试中所涉及的伦理，医学和政治因素。为此，在审查RCT的“黄金标准”地位、RCT中伦理学的作用以及将PrEP药丸作为单一实体颁布时，阐述并部署了“事件”的关键概念。此外，作者参与情感，拓扑和虚拟维度，以展示PrEP的结局如何也允许新的科学和伦理问题被制作。
Drawing on process thinkers as Whitehead, Deleuze and Stengers, Innovation and Biomedicine develops a framework for the analysis of Biomedical Innovation. With its sustained focus on the Pre-Exposure Prophylactic (PrEP) pill for the prevention of HIV infection, the volume explores the ethical, medical and political elements entailed in the pill's testing through offshore randomized control trials(RCTs). To this end, the key concept of 'eventuation' is elaborated and deployed in the scrutiny of 'gold standard' status of RCTs, the role of ethics in RCTs, and the enactment of the PrEP pill as a singular entity. Further, the authors engage with affective, topological and virtual dimensions to show how PrEP's eventuation also allows for new scientific and ethical questions to be crafted.